NO20004880L - Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap - Google Patents

Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap

Info

Publication number
NO20004880L
NO20004880L NO20004880A NO20004880A NO20004880L NO 20004880 L NO20004880 L NO 20004880L NO 20004880 A NO20004880 A NO 20004880A NO 20004880 A NO20004880 A NO 20004880A NO 20004880 L NO20004880 L NO 20004880L
Authority
NO
Norway
Prior art keywords
hair loss
retinoic acid
inhibitors
acid activity
reduce hair
Prior art date
Application number
NO20004880A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004880D0 (no
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO20004880D0 publication Critical patent/NO20004880D0/no
Publication of NO20004880L publication Critical patent/NO20004880L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20004880A 1998-03-31 2000-09-28 Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap NO20004880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (fr) 1998-03-31 1998-03-31 Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique
PCT/FR1999/000687 WO1999049838A1 (fr) 1998-03-31 1999-03-24 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour retarder la chute des cheveux

Publications (2)

Publication Number Publication Date
NO20004880D0 NO20004880D0 (no) 2000-09-28
NO20004880L true NO20004880L (no) 2000-11-30

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004880A NO20004880L (no) 1998-03-31 2000-09-28 Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap

Country Status (16)

Country Link
EP (1) EP1066017A1 (xx)
JP (1) JP2002509870A (xx)
KR (1) KR20010042104A (xx)
CN (1) CN1298290A (xx)
AR (1) AR015551A1 (xx)
AU (1) AU2938899A (xx)
BR (1) BR9908411A (xx)
CA (1) CA2324899A1 (xx)
FR (1) FR2776511B1 (xx)
HU (1) HUP0102411A3 (xx)
IL (1) IL137859A0 (xx)
NO (1) NO20004880L (xx)
PL (1) PL343004A1 (xx)
RU (1) RU2193877C2 (xx)
WO (1) WO1999049838A1 (xx)
ZA (1) ZA200004483B (xx)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
HUP9902645A3 (en) * 1996-03-18 1999-12-28 Eisai Co Ltd Fused-ring carboxylic acid derivatives

Also Published As

Publication number Publication date
WO1999049838A1 (fr) 1999-10-07
CN1298290A (zh) 2001-06-06
HUP0102411A3 (en) 2002-12-28
FR2776511B1 (fr) 2001-05-11
AU2938899A (en) 1999-10-18
PL343004A1 (en) 2001-07-30
ZA200004483B (en) 2002-02-27
EP1066017A1 (fr) 2001-01-10
HUP0102411A2 (hu) 2001-11-28
NO20004880D0 (no) 2000-09-28
CA2324899A1 (fr) 1999-10-07
FR2776511A1 (fr) 1999-10-01
JP2002509870A (ja) 2002-04-02
BR9908411A (pt) 2000-12-05
IL137859A0 (en) 2001-10-31
AR015551A1 (es) 2001-05-02
RU2193877C2 (ru) 2002-12-10
KR20010042104A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
WO1999046316A3 (en) Enzyme inhibitors
DE60115618D1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE254443T1 (de) Inhibitierung des haarwuchses
FI973492A0 (fi) NO-syntaasin estäjät
WO2003002114A3 (en) Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
NO20005162D0 (no) Forbindelser som inhiberer bindingen av integriner til deres reseptorer
NO20010844L (no) Regulering av substrataktivitet
MXPA04004479A (es) Composiciones topicas que contienen enzimas estabilizadas con inhibidores.
BR9811099A (pt) Inibidores de urocinase
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
NO20002479D0 (no) Kombinasjon av angiotensinkonverterende enzyminhibitor og et diuretikum for behandling av mikrosirkulatoriske forstyrrelser
WO2003035050A3 (en) Use of tyrosine kinase inhibitors for promoting hair growth
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
WO2003002107A3 (en) Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
WO2003002105A3 (en) Use of tyrosine kinase inhibitors for treating bone loss
ZA909124B (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
MX9805290A (es) Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta.
NO20003758L (no) Trekonserveringsmidler
NO20004880L (no) Anvendelse av inhibitorer av retinsyreaktivitet for å nedsette hårtap
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes